BMO Capital analyst John McNulty maintained a Buy rating on Ingevity (NYSE:NGVT) on Friday, setting a price target of $110, which is approximately 35.37% above the present share price of $81.26.
McNulty expects Ingevity to post earnings per share (EPS) of -$0.11 for the fourth quarter of 2021.
The current consensus among 2 TipRanks analysts is for a Moderate Buy rating of shares in Ingevity, with an average price target of $97.
The analysts price targets range from a high of $110 to a low of $84.
In its latest earnings report, released on 09/30/2021, the company reported a quarterly revenue of $376.8 million and a net profit of $91.5 million. The company's market cap is $3.19 billion.
According to TipRanks.com, BMO Capital analyst John McNulty is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 8.4% and a 66.39% success rate.
Ingevity Corp engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.